Composition:
Metformin 850 mg tablets with IPR (Immediate and Patterned Release technology)
Mechanism of Action:
Metformin, belonging to the class of anti-diabetes drugs, Biguanide, improves insulin sensitivity. Its extra pancreatic actions include reduction of hepatic glucose production, potentiation of insulin actions, increased peripheral utilisation of glucose and delayed intestinal absorption of sugars and starches.
Indications:
- In the treatment of type II diabetes mellitus
- Used as a single drug or in combination with other drugs e.g. glimepiride, pioglitazone, etc. to control blood glucose levels
Metadoze IPR incorporates a unique technology which enables immediate and sustained release of Metformin. This not only makes Metformin longer acting, but also improves absorption and reduces side effects.
No comments:
Post a Comment